Patents by Inventor Simon Kwok

Simon Kwok has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PROPHYLATIC APPETITE SUPPRESSION
    Publication number: 20160354348
    Abstract: Pharmaceutical formulations comprise sustained-release zonisamide. Methods of preparing such pharmaceutical formulations involve intermixing zonisamide with a suitable excipient configured to control the dissolution profile of the zonisamide. Methods of treatment involve administering the pharmaceutical formulations to patients in need of such treatment.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 8, 2016
    Inventors: Anthony A. McKinney, Gary Tollefson, Simon Kwok-Pan Yau, Ronald S. Vladyka, Rick Soltero
  • METHODS FOR PROPHYLATIC APPETITE SUPPRESSION
    Publication number: 20140080857
    Abstract: Pharmaceutical formulations comprise sustained-release zonisamide. Methods of preparing such pharmaceutical formulations involve intermixing zonisamide with a suitable excipient configured to control the dissolution profile of the zonisamide. Methods of treatment involve administering the pharmaceutical formulations to patients in need of such treatment.
    Type: Application
    Filed: August 13, 2013
    Publication date: March 20, 2014
    Applicant: Orexigen Therapeutics, Inc.
    Inventors: Anthony A. McKinney, Gary Tollefson, Simon Kwok-Pan Yau, Ronald S. Vladyka, Rick Soltero
  • A1 ADENOSINE RECEPTOR AGONIST POLYMORPHS
    Publication number: 20110039799
    Abstract: Provided are polymorphs of an A1 adenosine receptor partial agonist, compositions thereof, methods for their preparation, and methods for their uses.
    Type: Application
    Filed: August 10, 2010
    Publication date: February 17, 2011
    Applicant: Gilead Palo Alto, Inc.
    Inventors: Ernest Anthony Carra, Benjamin R. Graetz, DeMei Leung, Janaki Nyshadham, Robert Seemayer, Simon Kwok-Pan Yau
  • Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof
    Patent number: 6790622
    Abstract: This invention provides a novel nucleic acid molecule encoding PTX1, which has been mapped to human chromosome 12. The PTX1-encoding nucleic acid molecule, along with its encoded protein and antibodies thereto may be used to advantage to facilitate the diagnosis, prognosis and treatment of cancer.
    Type: Grant
    Filed: March 8, 2002
    Date of Patent: September 14, 2004
    Assignee: Albert Einstein Healthcare Network
    Inventors: Simon Kwok, Ierachimiel Daskal
  • Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof
    Patent number: 6743603
    Abstract: This invention provides a novel nucleic acid molecule encoding PTX1, which has been mapped to human chromosome 12. The PTX1-encoding nucleic acid molecule, along with its encoded protein and antibodies thereto may be used to advantage to facilitate the diagnosis, prognosis and treatment of cancer.
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: June 1, 2004
    Assignee: Albert Einstein Healthcare Network
    Inventors: Simon Kwok, Ierachimiel Daskal
  • Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof
    Publication number: 20020132262
    Abstract: This invention provides a novel nucleic acid molecule encoding PTX1, which has been mapped to human chromosome 12. The PTX1-encoding nucleic acid molecule, along with its encoded protein and antibodies thereto may be used to advantage to facilitate the diagnosis, prognosis and treatment of cancer.
    Type: Application
    Filed: March 8, 2002
    Publication date: September 19, 2002
    Inventors: Simon Kwok, Ierachimiel Daskal
  • Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof
    Publication number: 20020045217
    Abstract: This invention provides a novel nucleic acid molecule encoding PTX1, which has been mapped to human chromosome 12. The PTX1-encoding nucleic acid molecule, along with its encoded protein and antibodies thereto may be used to advantage to facilitate the diagnosis, prognosis and treatment of cancer.
    Type: Application
    Filed: August 22, 2001
    Publication date: April 18, 2002
    Inventors: Simon Kwok, Ierachimiel Daskal